Dong-Il Kim
Vermogen: 5 690 $ op 31-08-2026
Vermogen: 5 690 $ op 31-08-2026
Dong-Il Kim is currently an Independent Director at SunBio, Inc. since 2025 and a Professor at Inha University since 2012.
Former positions include Independent Director roles at SunBio, Inc. and Celltrion, Inc. Education includes a doctorate from Rutgers State University of New Jersey conferred in 1989, and undergraduate and graduate degrees from Seoul National University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SUNBIO, INC. 0,01% | 30-09-2025 | 1.250 ( 0,01% ) | 5 690 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SUNBIO,INC. | Directeur/Bestuurslid | 31-03-2025 |
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-06-2011 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SUNBIO,INC. | Directeur/Bestuurslid | - |
| CELLTRION, INC. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SunBio, Inc.
SunBio, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies biopharmaceuticals, bio-similars and medical devices | Health Technology |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltrion, Inc.
Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau